If you're looking for stocks that can deliver better-than-average returns in the long run, you might want to consider these two biotechs: Exact Sciences (NASDAQ: EXAS) and Vertex Pharmaceuticals (NASDAQ: VRTX). Both companies have innovative products that address sizable markets, along with robust pipelines that offer shareholders exceptional deep value. Here's why they could make you richer in 2023 and beyond.

Image source: Getty Images.

Exact Sciences is the company behind Cologuard, a noninvasive test that can detect colorectal cancer and a fair amount of pre-cancerous polyps from a stool sample. Colorectal cancer is the second-leading cause of cancer deaths in the U.S., but it can be prevented or cured if detected early.

Continue reading

Source Fool.com